Vinblastine Sulphate in the Treatment of Malignant Disease
Author Information
Author(s): N. M. Bleehen, A. M. Jelliffe
Primary Institution: The Middlesex Hospital, London
Hypothesis
Vinblastine sulphate is an effective treatment for advanced malignant disease.
Conclusion
Vinblastine is highly effective for managing various malignant lymphomas, particularly Hodgkin's disease, with minor side effects.
Supporting Evidence
- Vinblastine showed a good response in Hodgkin's disease within 1-2 weeks of treatment.
- 91 out of 116 patients treated with intermittent intravenous injection received adequate treatment for assessment.
- Vinblastine is considered the most effective and least toxic agent for controlling systemic Hodgkin's disease.
Takeaway
Vinblastine is a medicine that helps treat certain types of cancer, especially one called Hodgkin's disease, and it usually doesn't cause many bad side effects.
Methodology
Patients received vinblastine primarily through intermittent intravenous injection, with varying dosages based on individual tolerance.
Limitations
The study primarily focuses on the use of vinblastine for lymphomas, and results for other cancer types were less promising.
Participant Demographics
Patients primarily had advanced malignant lymphomas, with some suffering from other types of cancer.
Want to read the original?
Access the complete publication on the publisher's website